GB2559369A - Pharmaceutical and cleaning compositions and their use in treatment - Google Patents

Pharmaceutical and cleaning compositions and their use in treatment Download PDF

Info

Publication number: GB2559369A
Authority: GB; United Kingdom
Prior art keywords: methyl carbonate; wound; disease; pharmaceutical composition; methoxycarbonyl methyl
Prior art date: 2017-02-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

GB1701765.8A

Other languages

English (en)

Other versions

GB201701765D0 (en

Inventor

Vaughan Jerome

Hill Gregg

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Vornagain Ltd

Original Assignee

Vornagain Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-02-03

Filing date

2017-02-03

Publication date

2018-08-08

2017-02-03 Application filed by Vornagain Ltd filed Critical Vornagain Ltd

2017-02-03 Priority to GB1701765.8A priority Critical patent/GB2559369A/en

2017-03-22 Publication of GB201701765D0 publication Critical patent/GB201701765D0/en

2018-01-16 Priority to PCT/GB2018/050104 priority patent/WO2018142101A1/fr

2018-08-08 Publication of GB2559369A publication Critical patent/GB2559369A/en

Status Withdrawn legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title claims abstract description 52
238000011282 treatment Methods 0.000 title claims abstract description 51
238000004140 cleaning Methods 0.000 title claims abstract description 31
GZDFHIJNHHMENY-UHFFFAOYSA-N Dimethyl dicarbonate Chemical compound COC(=O)OC(=O)OC GZDFHIJNHHMENY-UHFFFAOYSA-N 0.000 claims abstract description 127
235000010300 dimethyl dicarbonate Nutrition 0.000 claims abstract description 127
206010052428 Wound Diseases 0.000 claims abstract description 96
208000027418 Wounds and injury Diseases 0.000 claims abstract description 94
239000008194 pharmaceutical composition Substances 0.000 claims abstract description 70
238000000034 method Methods 0.000 claims abstract description 35
239000003085 diluting agent Substances 0.000 claims abstract description 30
230000001954 sterilising effect Effects 0.000 claims abstract description 26
208000015181 infectious disease Diseases 0.000 claims abstract description 24
208000035473 Communicable disease Diseases 0.000 claims abstract description 17
201000010099 disease Diseases 0.000 claims abstract description 15
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 15
230000029663 wound healing Effects 0.000 claims abstract description 15
230000002500 effect on skin Effects 0.000 claims abstract description 13
230000002265 prevention Effects 0.000 claims abstract description 11
230000000249 desinfective effect Effects 0.000 claims abstract description 10
208000004396 mastitis Diseases 0.000 claims abstract description 10
239000003960 organic solvent Substances 0.000 claims abstract description 10
238000011200 topical administration Methods 0.000 claims abstract description 9
229930195733 hydrocarbon Natural products 0.000 claims abstract description 8
150000002430 hydrocarbons Chemical class 0.000 claims abstract description 8
239000001993 wax Substances 0.000 claims abstract description 8
239000012169 petroleum derived wax Substances 0.000 claims abstract description 7
235000019381 petroleum wax Nutrition 0.000 claims abstract description 7
239000003937 drug carrier Substances 0.000 claims abstract description 6
208000017520 skin disease Diseases 0.000 claims abstract description 6
239000004215 Carbon black (E152) Substances 0.000 claims abstract description 5
239000003814 drug Substances 0.000 claims abstract description 4
208000031888 Mycoses Diseases 0.000 claims description 15
208000002474 Tinea Diseases 0.000 claims description 11
239000002250 absorbent Substances 0.000 claims description 10
230000002745 absorbent Effects 0.000 claims description 10
239000008365 aqueous carrier Substances 0.000 claims description 10
208000035143 Bacterial infection Diseases 0.000 claims description 6
206010017533 Fungal infection Diseases 0.000 claims description 6
208000022362 bacterial infectious disease Diseases 0.000 claims description 5
241001460074 Microsporum distortum Species 0.000 claims description 4
125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 4
CXHHBNMLPJOKQD-UHFFFAOYSA-M methyl carbonate Chemical compound COC([O-])=O CXHHBNMLPJOKQD-UHFFFAOYSA-M 0.000 claims description 4
230000003612 virological effect Effects 0.000 claims description 4
206010012504 Dermatophytosis Diseases 0.000 claims description 3
210000000416 exudates and transudate Anatomy 0.000 claims description 2
208000024386 fungal infectious disease Diseases 0.000 claims description 2
239000004316 dimethyl dicarbonate Substances 0.000 abstract description 5
210000003491 skin Anatomy 0.000 description 22
235000013336 milk Nutrition 0.000 description 16
239000008267 milk Substances 0.000 description 16
210000004080 milk Anatomy 0.000 description 16
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
-1 hexane and pentane) Chemical class 0.000 description 15
241000894006 Bacteria Species 0.000 description 14
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
239000008367 deionised water Substances 0.000 description 14
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
239000004599 antimicrobial Substances 0.000 description 12
235000019271 petrolatum Nutrition 0.000 description 12
241000588724 Escherichia coli Species 0.000 description 10
229960005475 antiinfective agent Drugs 0.000 description 10
150000001875 compounds Chemical class 0.000 description 10
235000019441 ethanol Nutrition 0.000 description 10
229920000858 Cyclodextrin Polymers 0.000 description 9
241001465754 Metazoa Species 0.000 description 9
241001494479 Pecora Species 0.000 description 9
239000003795 chemical substances by application Substances 0.000 description 9
239000004744 fabric Substances 0.000 description 9
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
208000010801 foot rot Diseases 0.000 description 8
239000002280 amphoteric surfactant Substances 0.000 description 7
239000006071 cream Substances 0.000 description 7
239000000645 desinfectant Substances 0.000 description 7
239000012188 paraffin wax Substances 0.000 description 7
239000000546 pharmaceutical excipient Substances 0.000 description 7
239000007921 spray Substances 0.000 description 7
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
201000004624 Dermatitis Diseases 0.000 description 6
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
241000130764 Tinea Species 0.000 description 6
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
239000006260 foam Substances 0.000 description 6
210000000003 hoof Anatomy 0.000 description 6
239000007788 liquid Substances 0.000 description 6
239000000463 material Substances 0.000 description 6
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
239000002674 ointment Substances 0.000 description 6
239000004033 plastic Substances 0.000 description 6
229920003023 plastic Polymers 0.000 description 6
239000004094 surface-active agent Substances 0.000 description 6
241001480043 Arthrodermataceae Species 0.000 description 5
239000004166 Lanolin Substances 0.000 description 5
239000006142 Luria-Bertani Agar Substances 0.000 description 5
239000006137 Luria-Bertani broth Substances 0.000 description 5
210000004027 cell Anatomy 0.000 description 5
230000037304 dermatophytes Effects 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
239000000499 gel Substances 0.000 description 5
230000035876 healing Effects 0.000 description 5
235000019388 lanolin Nutrition 0.000 description 5
239000000243 solution Substances 0.000 description 5
239000002904 solvent Substances 0.000 description 5
WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 4
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
241000283690 Bos taurus Species 0.000 description 4
241000283707 Capra Species 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 4
206010061218 Inflammation Diseases 0.000 description 4
241001480037 Microsporum Species 0.000 description 4
OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
239000000839 emulsion Substances 0.000 description 4
230000002757 inflammatory effect Effects 0.000 description 4
230000004054 inflammatory process Effects 0.000 description 4
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
239000004200 microcrystalline wax Substances 0.000 description 4
235000019808 microcrystalline wax Nutrition 0.000 description 4
239000012454 non-polar solvent Substances 0.000 description 4
238000012856 packing Methods 0.000 description 4
239000003880 polar aprotic solvent Substances 0.000 description 4
239000003755 preservative agent Substances 0.000 description 4
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
239000003586 protic polar solvent Substances 0.000 description 4
238000004659 sterilization and disinfection Methods 0.000 description 4
210000001519 tissue Anatomy 0.000 description 4
229920001817 Agar Polymers 0.000 description 3
229920001450 Alpha-Cyclodextrin Polymers 0.000 description 3
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
241000195940 Bryophyta Species 0.000 description 3
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 3
240000004808 Saccharomyces cerevisiae Species 0.000 description 3
241000191940 Staphylococcus Species 0.000 description 3
241000223238 Trichophyton Species 0.000 description 3
241000223229 Trichophyton rubrum Species 0.000 description 3
239000000853 adhesive Substances 0.000 description 3
230000001070 adhesive effect Effects 0.000 description 3
239000008272 agar Substances 0.000 description 3
150000001298 alcohols Chemical class 0.000 description 3
229940043377 alpha-cyclodextrin Drugs 0.000 description 3
239000003945 anionic surfactant Substances 0.000 description 3
239000003963 antioxidant agent Substances 0.000 description 3
235000006708 antioxidants Nutrition 0.000 description 3
208000010668 atopic eczema Diseases 0.000 description 3
WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 3
229960004853 betadex Drugs 0.000 description 3
230000003115 biocidal effect Effects 0.000 description 3
239000000872 buffer Substances 0.000 description 3
239000003093 cationic surfactant Substances 0.000 description 3
GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 3
229940080345 gamma-cyclodextrin Drugs 0.000 description 3
230000001524 infective effect Effects 0.000 description 3
208000027866 inflammatory disease Diseases 0.000 description 3
229940039717 lanolin Drugs 0.000 description 3
239000006210 lotion Substances 0.000 description 3
235000011929 mousse Nutrition 0.000 description 3
239000002736 nonionic surfactant Substances 0.000 description 3
244000052769 pathogen Species 0.000 description 3
229940124531 pharmaceutical excipient Drugs 0.000 description 3
239000000843 powder Substances 0.000 description 3
239000003381 stabilizer Substances 0.000 description 3
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
241000222120 Candida <Saccharomycetales> Species 0.000 description 2
XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
206010012442 Dermatitis contact Diseases 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
206010014190 Eczema asteatotic Diseases 0.000 description 2
241001480035 Epidermophyton Species 0.000 description 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
241000233866 Fungi Species 0.000 description 2
241000282412 Homo Species 0.000 description 2
229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
235000019687 Lamb Nutrition 0.000 description 2
241000893980 Microsporum canis Species 0.000 description 2
201000009053 Neurodermatitis Diseases 0.000 description 2
239000004264 Petrolatum Substances 0.000 description 2
ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
229920003171 Poly (ethylene oxide) Chemical class 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
229920005830 Polyurethane Foam Polymers 0.000 description 2
229920002125 Sokalan® Polymers 0.000 description 2
241000191967 Staphylococcus aureus Species 0.000 description 2
206010041955 Stasis dermatitis Diseases 0.000 description 2
241000282887 Suidae Species 0.000 description 2
241000893966 Trichophyton verrucosum Species 0.000 description 2
241000186064 Trueperella pyogenes Species 0.000 description 2
208000036142 Viral infection Diseases 0.000 description 2
150000001335 aliphatic alkanes Chemical class 0.000 description 2
125000000129 anionic group Chemical group 0.000 description 2
235000010323 ascorbic acid Nutrition 0.000 description 2
239000011668 ascorbic acid Substances 0.000 description 2
235000013871 bee wax Nutrition 0.000 description 2
239000012166 beeswax Substances 0.000 description 2
229960000686 benzalkonium chloride Drugs 0.000 description 2
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
239000004203 carnauba wax Substances 0.000 description 2
235000013869 carnauba wax Nutrition 0.000 description 2
125000002091 cationic group Chemical group 0.000 description 2
229960002798 cetrimide Drugs 0.000 description 2
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
239000012459 cleaning agent Substances 0.000 description 2
239000003086 colorant Substances 0.000 description 2
239000008139 complexing agent Substances 0.000 description 2
150000001924 cycloalkanes Chemical class 0.000 description 2
229940097362 cyclodextrins Drugs 0.000 description 2
235000014113 dietary fatty acids Nutrition 0.000 description 2
229960004132 diethyl ether Drugs 0.000 description 2
229960001760 dimethyl sulfoxide Drugs 0.000 description 2
239000003995 emulsifying agent Substances 0.000 description 2
238000005538 encapsulation Methods 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
210000002615 epidermis Anatomy 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
239000000194 fatty acid Substances 0.000 description 2
229930195729 fatty acid Natural products 0.000 description 2
235000013305 food Nutrition 0.000 description 2
235000019253 formic acid Nutrition 0.000 description 2
230000006870 function Effects 0.000 description 2
230000002538 fungal effect Effects 0.000 description 2
DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 2
239000012051 hydrophobic carrier Substances 0.000 description 2
239000001863 hydroxypropyl cellulose Substances 0.000 description 2
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
230000001965 increasing effect Effects 0.000 description 2
238000011534 incubation Methods 0.000 description 2
239000002085 irritant Substances 0.000 description 2
231100000021 irritant Toxicity 0.000 description 2
239000002502 liposome Substances 0.000 description 2
229940057995 liquid paraffin Drugs 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
239000006072 paste Substances 0.000 description 2
239000002304 perfume Substances 0.000 description 2
229940066842 petrolatum Drugs 0.000 description 2
229940067107 phenylethyl alcohol Drugs 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
229920005862 polyol Polymers 0.000 description 2
239000011496 polyurethane foam Substances 0.000 description 2
230000035752 proliferative phase Effects 0.000 description 2
RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 2
QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
102220240796 rs553605556 Human genes 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
239000011734 sodium Substances 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
239000003871 white petrolatum Substances 0.000 description 2
239000002888 zwitterionic surfactant Substances 0.000 description 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
DYIOSHGVFJTOAR-JGWLITMVSA-N (2r,3r,4s,5r)-6-sulfanylhexane-1,2,3,4,5-pentol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CS DYIOSHGVFJTOAR-JGWLITMVSA-N 0.000 description 1
GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
JCIIKRHCWVHVFF-UHFFFAOYSA-N 1,2,4-thiadiazol-5-amine;hydrochloride Chemical compound Cl.NC1=NC=NS1 JCIIKRHCWVHVFF-UHFFFAOYSA-N 0.000 description 1
VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 description 1
RHEJCPIREFCJNF-UHFFFAOYSA-M 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-3-(2-phenylethyl)imidazol-1-ium;chloride Chemical compound [Cl-].ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)C[N+]1=CN(CCC=2C=CC=CC=2)C=C1 RHEJCPIREFCJNF-UHFFFAOYSA-M 0.000 description 1
FSKNXCHJIFBRBT-UHFFFAOYSA-N 2-[2-[2-(dodecylamino)ethylamino]ethylamino]acetic acid Chemical compound CCCCCCCCCCCCNCCNCCNCC(O)=O FSKNXCHJIFBRBT-UHFFFAOYSA-N 0.000 description 1
OTKWLUKIHNEGIG-UHFFFAOYSA-N 2-[3-(hexadecanoylamino)propyl-dimethylazaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O OTKWLUKIHNEGIG-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
208000002874 Acne Vulgaris Diseases 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical class CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
240000002339 Anredera cordifolia Species 0.000 description 1
241000050060 Arthroderma amazonicum Species 0.000 description 1
241001221859 Arthroderma flavescens Species 0.000 description 1
241001232752 Arthroderma gloriae Species 0.000 description 1
241000344502 Arthroderma onychocola Species 0.000 description 1
241000033579 Arthroderma phaseoliforme Species 0.000 description 1
241000924013 Arthroderma redellii Species 0.000 description 1
241001260018 Arthroderma uncinatum Species 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
206010005913 Body tinea Diseases 0.000 description 1
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
241001148106 Brucella melitensis Species 0.000 description 1
239000004255 Butylated hydroxyanisole Substances 0.000 description 1
239000004322 Butylated hydroxytoluene Substances 0.000 description 1
NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
241000222178 Candida tropicalis Species 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
241001508813 Clavispora lusitaniae Species 0.000 description 1
241001508000 Corynebacterium bovis Species 0.000 description 1
ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
206010012438 Dermatitis atopic Diseases 0.000 description 1
206010012441 Dermatitis bullous Diseases 0.000 description 1
206010051651 Dermatitis papillaris capillitii Diseases 0.000 description 1
241000187845 Dermatophilus congolensis Species 0.000 description 1
239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
OJIYIVCMRYCWSE-UHFFFAOYSA-M Domiphen bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1 OJIYIVCMRYCWSE-UHFFFAOYSA-M 0.000 description 1
208000019872 Drug Eruptions Diseases 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
241001480036 Epidermophyton floccosum Species 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
244000228957 Ferula foetida Species 0.000 description 1
241000605952 Fusobacterium necrophorum Species 0.000 description 1
239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
238000012404 In vitro experiment Methods 0.000 description 1
208000011200 Kawasaki disease Diseases 0.000 description 1
206010023330 Keloid scar Diseases 0.000 description 1
241000588915 Klebsiella aerogenes Species 0.000 description 1
241000588749 Klebsiella oxytoca Species 0.000 description 1
241000588747 Klebsiella pneumoniae Species 0.000 description 1
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
241000235428 Lagenidium Species 0.000 description 1
206010024434 Lichen sclerosus Diseases 0.000 description 1
241000989306 Lophophyton gallinae Species 0.000 description 1
241001480000 Microsporum audouinii Species 0.000 description 1
241001260008 Microsporum equinum Species 0.000 description 1
241001299895 Microsporum ferrugineum Species 0.000 description 1
241001260021 Microsporum langeronii Species 0.000 description 1
241001260007 Microsporum rivalieri Species 0.000 description 1
241000204031 Mycoplasma Species 0.000 description 1
241000573520 Nannizzia duboisii Species 0.000 description 1
241000893974 Nannizzia fulva Species 0.000 description 1
241000893976 Nannizzia gypsea Species 0.000 description 1
241000264375 Nannizzia nana Species 0.000 description 1
241000921804 Nannizzia persicolor Species 0.000 description 1
241000033578 Nannizzia praecox Species 0.000 description 1
241000233654 Oomycetes Species 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241000606860 Pasteurella Species 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
229920002413 Polyhexanide Polymers 0.000 description 1
241001135223 Prevotella melaninogenica Species 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
241000588769 Proteus <enterobacteria> Species 0.000 description 1
208000003251 Pruritus Diseases 0.000 description 1
241000589517 Pseudomonas aeruginosa Species 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
241000233639 Pythium Species 0.000 description 1
241001303601 Rosacea Species 0.000 description 1
206010039710 Scleroderma Diseases 0.000 description 1
206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
206010070834 Sensitisation Diseases 0.000 description 1
208000019802 Sexually transmitted disease Diseases 0.000 description 1
206010048676 Sjogren-Larsson Syndrome Diseases 0.000 description 1
DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
229920002385 Sodium hyaluronate Polymers 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
241000191963 Staphylococcus epidermidis Species 0.000 description 1
241000193985 Streptococcus agalactiae Species 0.000 description 1
241000194054 Streptococcus uberis Species 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
206010053615 Thermal burn Diseases 0.000 description 1
206010043866 Tinea capitis Diseases 0.000 description 1
201000010618 Tinea cruris Diseases 0.000 description 1
206010067719 Tinea faciei Diseases 0.000 description 1
206010043870 Tinea infections Diseases 0.000 description 1
206010067197 Tinea manuum Diseases 0.000 description 1
206010043871 Tinea nigra Diseases 0.000 description 1
206010051446 Transient acantholytic dermatosis Diseases 0.000 description 1
241000893963 Trichophyton concentricum Species 0.000 description 1
241000893962 Trichophyton equinum Species 0.000 description 1
241001045773 Trichophyton erinacei Species 0.000 description 1
241001459572 Trichophyton interdigitale Species 0.000 description 1
241001480046 Trichophyton schoenleinii Species 0.000 description 1
241000893982 Trichophyton simii Species 0.000 description 1
241000985906 Trichophyton soudanense Species 0.000 description 1
241001609978 Trichophyton terrestre Species 0.000 description 1
241001480048 Trichophyton tonsurans Species 0.000 description 1
241001244272 Trichophyton vanbreuseghemii Species 0.000 description 1
241001480050 Trichophyton violaceum Species 0.000 description 1
241001621834 Trichophyton yaoundei Species 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
208000024780 Urticaria Diseases 0.000 description 1
241000700605 Viruses Species 0.000 description 1
241000222126 [Candida] glabrata Species 0.000 description 1
241000994262 [Microsporum] boullardii Species 0.000 description 1
229960004308 acetylcysteine Drugs 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
206010000496 acne Diseases 0.000 description 1
208000009621 actinic keratosis Diseases 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
208000002029 allergic contact dermatitis Diseases 0.000 description 1
239000000956 alloy Substances 0.000 description 1
229910045601 alloy Inorganic materials 0.000 description 1
229940087168 alpha tocopherol Drugs 0.000 description 1
HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
229940031955 anhydrous lanolin Drugs 0.000 description 1
235000020244 animal milk Nutrition 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000000843 anti-fungal effect Effects 0.000 description 1
230000002924 anti-infective effect Effects 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
230000002421 anti-septic effect Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
229940072107 ascorbate Drugs 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
201000008937 atopic dermatitis Diseases 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
229960001950 benzethonium chloride Drugs 0.000 description 1
229960001574 benzoxonium chloride Drugs 0.000 description 1
235000019445 benzyl alcohol Nutrition 0.000 description 1
229960004217 benzyl alcohol Drugs 0.000 description 1
150000004283 biguanides Chemical class 0.000 description 1
239000007844 bleaching agent Substances 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
229940038698 brucella melitensis Drugs 0.000 description 1
235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
229940043253 butylated hydroxyanisole Drugs 0.000 description 1
235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
229940095259 butylated hydroxytoluene Drugs 0.000 description 1
229940095731 candida albicans Drugs 0.000 description 1
208000032343 candida glabrata infection Diseases 0.000 description 1
229960001631 carbomer Drugs 0.000 description 1
150000007942 carboxylates Chemical class 0.000 description 1
230000006041 cell recruitment Effects 0.000 description 1
239000007765 cera alba Substances 0.000 description 1
239000007766 cera flava Substances 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
229960001927 cetylpyridinium chloride Drugs 0.000 description 1
YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
229960003260 chlorhexidine Drugs 0.000 description 1
229960004926 chlorobutanol Drugs 0.000 description 1
239000002131 composite material Substances 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
230000003750 conditioning effect Effects 0.000 description 1
208000010247 contact dermatitis Diseases 0.000 description 1
238000011109 contamination Methods 0.000 description 1
235000014510 cooky Nutrition 0.000 description 1
235000020247 cow milk Nutrition 0.000 description 1
208000024526 cutaneous mucinosis Diseases 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
229960002433 cysteine Drugs 0.000 description 1
ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
210000004207 dermis Anatomy 0.000 description 1
239000003599 detergent Substances 0.000 description 1
235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
229940044165 dodicin Drugs 0.000 description 1
229960001859 domiphen bromide Drugs 0.000 description 1
230000000694 effects Effects 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
239000003974 emollient agent Substances 0.000 description 1
239000008393 encapsulating agent Substances 0.000 description 1
229940092559 enterobacter aerogenes Drugs 0.000 description 1
BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
229940052303 ethers for general anesthesia Drugs 0.000 description 1
SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
238000009313 farming Methods 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
150000002191 fatty alcohols Chemical class 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
239000002657 fibrous material Substances 0.000 description 1
239000006261 foam material Substances 0.000 description 1
239000004088 foaming agent Substances 0.000 description 1
210000002683 foot Anatomy 0.000 description 1
244000053095 fungal pathogen Species 0.000 description 1
ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
229940050410 gluconate Drugs 0.000 description 1
150000002314 glycerols Chemical class 0.000 description 1
DKPHLYCEFBDQKM-UHFFFAOYSA-H hexapotassium;1-phosphonato-n,n-bis(phosphonatomethyl)methanamine Chemical compound [K+].[K+].[K+].[K+].[K+].[K+].[O-]P([O-])(=O)CN(CP([O-])([O-])=O)CP([O-])([O-])=O DKPHLYCEFBDQKM-UHFFFAOYSA-H 0.000 description 1
229920002674 hyaluronan Polymers 0.000 description 1
229960003160 hyaluronic acid Drugs 0.000 description 1
239000000017 hydrogel Substances 0.000 description 1
GBHRVZIGDIUCJB-UHFFFAOYSA-N hydrogenphosphite Chemical class OP([O-])[O-] GBHRVZIGDIUCJB-UHFFFAOYSA-N 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
230000001969 hypertrophic effect Effects 0.000 description 1
150000002462 imidazolines Chemical class 0.000 description 1
ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
230000004968 inflammatory condition Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
239000002563 ionic surfactant Substances 0.000 description 1
230000007794 irritation Effects 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
230000003902 lesion Effects 0.000 description 1
201000011486 lichen planus Diseases 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
230000035800 maturation Effects 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
229960002216 methylparaben Drugs 0.000 description 1
PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
208000001725 mucocutaneous lymph node syndrome Diseases 0.000 description 1
230000037311 normal skin Effects 0.000 description 1
239000006916 nutrient agar Substances 0.000 description 1
125000005430 oxychloro group Chemical group 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
229950007703 pendecamaine Drugs 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
229940083254 peripheral vasodilators imidazoline derivative Drugs 0.000 description 1
239000003209 petroleum derivative Substances 0.000 description 1
229940096826 phenylmercuric acetate Drugs 0.000 description 1
229960000247 phenylmercuric borate Drugs 0.000 description 1
VUXSPDNLYQTOSY-UHFFFAOYSA-N phenylmercuric borate Chemical compound OB(O)O[Hg]C1=CC=CC=C1 VUXSPDNLYQTOSY-UHFFFAOYSA-N 0.000 description 1
PDTFCHSETJBPTR-UHFFFAOYSA-N phenylmercuric nitrate Chemical compound [O-][N+](=O)O[Hg]C1=CC=CC=C1 PDTFCHSETJBPTR-UHFFFAOYSA-N 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000011505 plaster Substances 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920000768 polyamine Polymers 0.000 description 1
239000001253 polyvinylpolypyrrolidone Substances 0.000 description 1
235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000011148 porous material Substances 0.000 description 1
159000000001 potassium salts Chemical class 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
CIBMHJPPKCXONB-UHFFFAOYSA-N propane-2,2-diol Chemical compound CC(C)(O)O CIBMHJPPKCXONB-UHFFFAOYSA-N 0.000 description 1
235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
229960003415 propylparaben Drugs 0.000 description 1
PXGPLTODNUVGFL-JZFBHDEDSA-N prostaglandin F2beta Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H](O)[C@@H]1C\C=C/CCCC(O)=O PXGPLTODNUVGFL-JZFBHDEDSA-N 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
208000017940 prurigo nodularis Diseases 0.000 description 1
230000001823 pruritic effect Effects 0.000 description 1
230000001185 psoriatic effect Effects 0.000 description 1
208000008666 pythiosis Diseases 0.000 description 1
150000003242 quaternary ammonium salts Chemical class 0.000 description 1
238000009877 rendering Methods 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011347 resin Substances 0.000 description 1
201000004700 rosacea Diseases 0.000 description 1
239000005060 rubber Substances 0.000 description 1
231100000241 scar Toxicity 0.000 description 1
230000036573 scar formation Effects 0.000 description 1
230000037390 scarring Effects 0.000 description 1
HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
208000008742 seborrheic dermatitis Diseases 0.000 description 1
230000008313 sensitization Effects 0.000 description 1
229950003422 sepazonium chloride Drugs 0.000 description 1
239000011257 shell material Substances 0.000 description 1
206010040872 skin infection Diseases 0.000 description 1
239000000344 soap Substances 0.000 description 1
229940010747 sodium hyaluronate Drugs 0.000 description 1
235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
239000004289 sodium hydrogen sulphite Substances 0.000 description 1
235000019333 sodium laurylsulphate Nutrition 0.000 description 1
229960001922 sodium perborate Drugs 0.000 description 1
239000012418 sodium perborate tetrahydrate Substances 0.000 description 1
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
IBDSNZLUHYKHQP-UHFFFAOYSA-N sodium;3-oxidodioxaborirane;tetrahydrate Chemical compound O.O.O.O.[Na+].[O-]B1OO1 IBDSNZLUHYKHQP-UHFFFAOYSA-N 0.000 description 1
YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
235000010199 sorbic acid Nutrition 0.000 description 1
239000004334 sorbic acid Substances 0.000 description 1
229940075582 sorbic acid Drugs 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
241000894007 species Species 0.000 description 1
238000005507 spraying Methods 0.000 description 1
206010041823 squamous cell carcinoma Diseases 0.000 description 1
229940030998 streptococcus agalactiae Drugs 0.000 description 1
229940115922 streptococcus uberis Drugs 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
239000000725 suspension Substances 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229960004906 thiomersal Drugs 0.000 description 1
NBOMNTLFRHMDEZ-UHFFFAOYSA-N thiosalicylic acid Chemical class OC(=O)C1=CC=CC=C1S NBOMNTLFRHMDEZ-UHFFFAOYSA-N 0.000 description 1
201000003875 tinea corporis Diseases 0.000 description 1
201000004647 tinea pedis Diseases 0.000 description 1
229960000984 tocofersolan Drugs 0.000 description 1
AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
229940042585 tocopherol acetate Drugs 0.000 description 1
239000012049 topical pharmaceutical composition Substances 0.000 description 1
230000008733 trauma Effects 0.000 description 1
229940055035 trichophyton verrucosum Drugs 0.000 description 1
238000009966 trimming Methods 0.000 description 1
244000052613 viral pathogen Species 0.000 description 1
239000002023 wood Substances 0.000 description 1
210000002268 wool Anatomy 0.000 description 1
239000003357 wound healing promoting agent Substances 0.000 description 1
239000000230 xanthan gum Substances 0.000 description 1
229920001285 xanthan gum Polymers 0.000 description 1
235000010493 xanthan gum Nutrition 0.000 description 1
229940082509 xanthan gum Drugs 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1
239000002076 α-tocopherol Substances 0.000 description 1
235000004835 α-tocopherol Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/02—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Oil, Petroleum & Natural Gas (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Materials Engineering (AREA)
Hematology (AREA)
Dermatology (AREA)
Dentistry (AREA)
Pest Control & Pesticides (AREA)
Plant Pathology (AREA)
Agronomy & Crop Science (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Environmental Sciences (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GB1701765.8A 2017-02-03 2017-02-03 Pharmaceutical and cleaning compositions and their use in treatment Withdrawn GB2559369A (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GB1701765.8A GB2559369A (en)	2017-02-03	2017-02-03	Pharmaceutical and cleaning compositions and their use in treatment
PCT/GB2018/050104 WO2018142101A1 (fr)	2017-02-03	2018-01-16	Compositions pharmaceutiques et de nettoyage et leur utilisation en traitement

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB1701765.8A GB2559369A (en)	2017-02-03	2017-02-03	Pharmaceutical and cleaning compositions and their use in treatment

Publications (2)

Publication Number	Publication Date
GB201701765D0 GB201701765D0 (en)	2017-03-22
GB2559369A true GB2559369A (en)	2018-08-08

Family

ID=58462329

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB1701765.8A Withdrawn GB2559369A (en)	2017-02-03	2017-02-03	Pharmaceutical and cleaning compositions and their use in treatment

Country Status (2)

Country	Link
GB (1)	GB2559369A (fr)
WO (1)	WO2018142101A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1392905A (en) *	1972-02-17	1975-05-07	Pierrefitte Auby Sa	Therapeutic composition for medical veterinary of cosmeto- logical use
US20120232154A1 (en) *	2006-07-29	2012-09-13	Lanxess Deutschland Gmbh	Preservatives based on carboxylic anhydrides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2911208A1 (de) *	1979-03-22	1980-10-02	Bayer Ag	Mikrobizides mittel und seine verwendung
WO2006048457A1 (fr) *	2004-11-05	2006-05-11	Dsm Ip Assets B.V.	Probiotiques et polyphenol

2017
- 2017-02-03 GB GB1701765.8A patent/GB2559369A/en not_active Withdrawn
2018
- 2018-01-16 WO PCT/GB2018/050104 patent/WO2018142101A1/fr not_active Ceased

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1392905A (en) *	1972-02-17	1975-05-07	Pierrefitte Auby Sa	Therapeutic composition for medical veterinary of cosmeto- logical use
US20120232154A1 (en) *	2006-07-29	2012-09-13	Lanxess Deutschland Gmbh	Preservatives based on carboxylic anhydrides

Also Published As

Publication number	Publication date
WO2018142101A1 (fr)	2018-08-09
GB201701765D0 (en)	2017-03-22

Publication	Publication Date	Title
EP2916820B1 (fr)	2023-10-11	Administration d'agents biologiquement actifs à l'aide de solvants hydrophobes, volatils
US8968794B2 (en)	2015-03-03	Antiseptic compositions and uses thereof
US20100215707A1 (en)	2010-08-26	Activated creatinine and precursors thereof as antibacterial agents, compositions and products containing such agents and uses thereof
EP2849777B1 (fr)	2017-10-18	Seaprose pour retirer un biofilm bactérien
JP2012523449A (ja)	2012-10-04	スルファジアジン銀およびキトサンを使用して製造された薬用クリーム剤ならびにそれを製造する方法
EP2496215A2 (fr)	2012-09-12	Formulations antimicrobielles et anti-acne
US11331289B2 (en)	2022-05-17	Antimicrobial composition
WO2015120310A1 (fr)	2015-08-13	Méthodes de décolonisation de staphylococcus aureus
GB2559369A (en)	2018-08-08	Pharmaceutical and cleaning compositions and their use in treatment
EP3210619A2 (fr)	2017-08-30	Formulation topique pour le traitement d'infections de la peau ou des muqueuses, procédé de préparation et utilisations correspondantes
CN112236163B (zh)	2024-07-02	使用协同量的硼酸增强缩酚酸肽抗生素的抗菌作用
RU2536266C2 (ru)	2014-12-20	Крем медицинского назначения, изготовленный с использованием фрамицетина сульфата и хитозана, и способ его изготовления
US20170071973A1 (en)	2017-03-16	Extended shelf life wound healing formulation
EP2704730B1 (fr)	2019-11-13	Traitement d'origine aviaire pour infections microbiennes
RU2808365C1 (ru)	2023-11-28	Способ местного лечения гнойно-воспалительного процесса кожи и мягких тканей.
JP4709489B2 (ja)	2011-06-22	創傷治癒のためのヒドロキシピリドン誘導体の使用
US10905729B1 (en)	2021-02-02	Formulations and methods for wound treatment
JP7253128B2 (ja)	2023-04-06	デプシペプチド系抗生物質を含有する外用組成物
JP2024128672A (ja)	2024-09-24	顔の皮膚状態の改善剤
WO2014205519A1 (fr)	2014-12-31	Compositions antimicrobiennes et procédés d'utilisation
HK1212231B (en)	2023-11-17	Delivery of biologically-active agents using volatile, hydrophobic solvents

Legal Events

Date	Code	Title	Description
2019-06-26	WAP	Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)